EVOLOCUMAB

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Name

Type

Language

EVOLOCUMAB (GENETICAL RECOMBINATION)

Preferred Name

English

EVOLOCUMAB

Official Name

English

EVOLOCUMAB [JAN]

Common Name

English

REPATHA

Brand Name

English

EVOLOCUMAB [PURPLE BOOK CDER]

Common Name

English

IMMUNOGLOBULIN G2-LAMBDA, ANTI-(HOMO SAPIENS PCSK9 (PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9)), HOMO SAPIENS MONOCLONAL ANTIBODY

Common Name

English

evolocumab [INN]

Common Name

English

Evolocumab [WHO-DD]

Common Name

English

AMG-145

Code

English

EVOLOCUMAB [USAN]

Common Name

English

EVOLOCUMAB [MI]

Common Name

English

Classification Tree Code System Code

NDF-RT

N0000191731

Created by admin on Mon Mar 31 21:39:54 GMT 2025 , Edited by admin on Mon Mar 31 21:39:54 GMT 2025

FDA ORPHAN DRUG

404113

Created by admin on Mon Mar 31 21:39:54 GMT 2025 , Edited by admin on Mon Mar 31 21:39:54 GMT 2025

WHO-ATC

C10AX13

Created by admin on Mon Mar 31 21:39:54 GMT 2025 , Edited by admin on Mon Mar 31 21:39:54 GMT 2025

Code System Code Type Description

DRUG BANK

DB09303

Created by admin on Mon Mar 31 21:39:54 GMT 2025 , Edited by admin on Mon Mar 31 21:39:54 GMT 2025

PRIMARY

EVMPD

SUB128552

Created by admin on Mon Mar 31 21:39:54 GMT 2025 , Edited by admin on Mon Mar 31 21:39:54 GMT 2025

PRIMARY

USAN

AB-13

Created by admin on Mon Mar 31 21:39:54 GMT 2025 , Edited by admin on Mon Mar 31 21:39:54 GMT 2025

PRIMARY

CAS

1256937-27-5

Created by admin on Mon Mar 31 21:39:54 GMT 2025 , Edited by admin on Mon Mar 31 21:39:54 GMT 2025

PRIMARY

HSDB

8307

Created by admin on Mon Mar 31 21:39:54 GMT 2025 , Edited by admin on Mon Mar 31 21:39:54 GMT 2025

PRIMARY

FDA UNII

LKC0U3A8NJ

Created by admin on Mon Mar 31 21:39:54 GMT 2025 , Edited by admin on Mon Mar 31 21:39:54 GMT 2025

PRIMARY

JAPANESE REVIEW

REPATHA

Created by admin on Mon Mar 31 21:39:54 GMT 2025 , Edited by admin on Mon Mar 31 21:39:54 GMT 2025

PRIMARY

APPROVED JANUARY 2016

LACTMED

Evolocumab

Created by admin on Mon Mar 31 21:39:54 GMT 2025 , Edited by admin on Mon Mar 31 21:39:54 GMT 2025

PRIMARY

ChEMBL

CHEMBL2364655

Created by admin on Mon Mar 31 21:39:54 GMT 2025 , Edited by admin on Mon Mar 31 21:39:54 GMT 2025

PRIMARY

MERCK INDEX

m11845

Created by admin on Mon Mar 31 21:39:54 GMT 2025 , Edited by admin on Mon Mar 31 21:39:54 GMT 2025

PRIMARY

IUPHAR

7343

Created by admin on Mon Mar 31 21:39:54 GMT 2025 , Edited by admin on Mon Mar 31 21:39:54 GMT 2025

PRIMARY

RXCUI

1665684

Created by admin on Mon Mar 31 21:39:54 GMT 2025 , Edited by admin on Mon Mar 31 21:39:54 GMT 2025

PRIMARY

RxNorm

NDF-RT

N0000191730

Created by admin on Mon Mar 31 21:39:54 GMT 2025 , Edited by admin on Mon Mar 31 21:39:54 GMT 2025

PRIMARY

PCSK9 Inhibitors [MoA]

NCI_THESAURUS

C174672

Created by admin on Mon Mar 31 21:39:54 GMT 2025 , Edited by admin on Mon Mar 31 21:39:54 GMT 2025

PRIMARY

DRUG CENTRAL

5000

Created by admin on Mon Mar 31 21:39:54 GMT 2025 , Edited by admin on Mon Mar 31 21:39:54 GMT 2025

PRIMARY

SMS_ID

100000154364

Created by admin on Mon Mar 31 21:39:54 GMT 2025 , Edited by admin on Mon Mar 31 21:39:54 GMT 2025

PRIMARY

DAILYMED

LKC0U3A8NJ

Created by admin on Mon Mar 31 21:39:54 GMT 2025 , Edited by admin on Mon Mar 31 21:39:54 GMT 2025

PRIMARY

WIKIPEDIA

EVOLOCUMAB

Created by admin on Mon Mar 31 21:39:54 GMT 2025 , Edited by admin on Mon Mar 31 21:39:54 GMT 2025

PRIMARY

CAS

1420806-15-0

Created by admin on Mon Mar 31 21:39:54 GMT 2025 , Edited by admin on Mon Mar 31 21:39:54 GMT 2025

SUPERSEDED

INN

9643

Created by admin on Mon Mar 31 21:39:54 GMT 2025 , Edited by admin on Mon Mar 31 21:39:54 GMT 2025

PRIMARY

ACTIVE MOIETY


					LKC0U3A8NJ